Illumina, Inc.
Author: Michael
GenSight Biologics S.A.
Fractyl Health, Inc.
A commentary issued on behalf of VentriPoint Diag
Alterity Therapeutics Ltd.
Correcting for extrinsic mortality suggests intr
Corsera COO explains why the biotech is building
Altimmune raises $75 million to advance pemvidut
PMD trial ties functional measures with NAD⁺ a
Juvenescence-backed biotech targets ‘continuou